Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr.Reddy's Laboratories informs about cessation of CO
Date: 17-03-2022Dr.Reddy's Laboratories has informed about Cessation of Vivek Mittal as interim Compliance Officer w.e.f. March 17, 2022 on account of appointment of K Randhir Singh as Company Secretary and Compliance Officer.
The above information is a part of company’s filings submitted to BSE.